Hypha Labs Inc の最大収益セグメントは Loan Facilitation Service - Direct Model - Xiaoying Credit Loan で、最新の利益発表における収益は 386,868,475 です。地域別に見ると、China が Hypha Labs Inc の主要市場であり、収益は 679,585,682 です。
Hypha Labs Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Hypha Labs Incの純損失は$-3です。
Hypha Labs Incに負債はありますか?
はい、Hypha Labs Incの負債は2です。
Hypha Labs Incの発行済株式数は何株ですか?
Hypha Labs Incの総発行済株式数は147.12株です。
主要データ
前終値
$0.0198
始値
$0.0198
当日レンジ
$0.0198 - $0.0198
52週レンジ
$0.0053 - $0.04
取引高
76.5K
平均取引高
132.8K
配当利回り
--
1株当たり利益(TTM)
-0.02
時価総額
$3.2M
FUNIとは何ですか?
Hypha Labs, Inc. engages in the research, development, and commercialization of a bioreactor. The company is headquartered in Las Vegas, Nevada and currently employs 5 full-time employees. The company went IPO on 2011-12-23. The Hypha Micropearl bioreactor is a home appliance designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company’s device, together with its replacement cartridges, produces enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contain active mushroom ingredients that offer a way to harness the medicinal properties of fungi in a concentrated easy to handle tasteless and odorless form. These Micropearls can be incorporated into various food and beverages without altering the flavor. The QR codes on the cartridges are scanned to the Hypha Lab app and inserted into the device and the Micropearls are produced and fully formed in eight days. Its Hypha Micropearl bioreactor is to be sold with replaceable cartridges.